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The ability to more continuously record out-of-clinic data is a critical component 
in the progress from the current hospital-centered healthcare system, which will continue 
to be stressed by the growing aging population, to one that is preventative and pervasive.  
In order to achieve this healthcare model, the development of robust acquisition systems 
which can be used in daily life for recording biomechanical measures is crucial.  Chronic 
diseases such as osteoarthritis and cardiovascular disease affect a large portion of aging 
adults and pose an immense financial burden on healthcare.  
This research investigates novel technologies for sensing clinically-relevant 
parameters for both of these prevalent disease groups, with a shared focus on wearable or 
unobtrusive biomechanical measurements. Specifically, knee joint acoustics and the 
vibrations of the body in response to the heartbeat are studied.  Both sets of measurements 
required the development of low-noise, analog front-end circuits, together with robust 
packaging tailored to facilitate high quality recordings in unsupervised settings. These 
systems are expected to provide high-quality data capture, while also maximizing user 




CHAPTER 1. INTRODUCTION 
Mortality rates due to communicable diseases continue to decline across the globe, 
confirming modern healthcare’s ability to identify and treat infectious diseases.  This feat, 
in addition to other factors, has led to the population of adults over the age of 65 being the 
most rapidly growing demographic worldwide [1].  Unfortunately, these aging adults are 
highly susceptible to developing chronic diseases such as cardiovascular disease (CVD), 
diabetes, and arthritis.  In fact, a 2008 study of adults in the United States over the age of 
65 showed that 92.2% reported suffering from one or more chronic diseases and 17.4% 
reported suffering from four or more chronic diseases representing an increase in both cases 
from 86.9% and 11.7%, respectively, in 1998 [2]. 
The subsequent effects of increased chronic disease rates and the resulting burdens 
on healthcare systems and economies across the globe have become evident – in 2002 
healthcare related costs of heart disease alone reached over $351 billion in the United States 
[3].  The working age population is dramatically affected by chronic disease as well.  The 
United States lost an estimated $3.3 trillion between 1994 and 2005 because of disability-
related costs for medical care and lost productivity [4].  Of the 47.5 million Americans on 
disability, 40% can be attributed to arthritis, spinal problems, and heart related diseases [4].  
Part of this immense financial burden can be attributed to the current hospital-centered 
healthcare system’s inefficiency in managing chronic diseases and to expensive 
interventions used for treatments that often do not solve the underlying cause of the 
physiological problem.   
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In contrast, if at-risk populations were continuously monitored, they could 
potentially be treated with preventative measures such as medication, physical therapy, and 
behavior modification upon risk identification in an attempt to prevent, or at least slow, 
chronic disease progression.  This kind of health management system would be 
personalized, data driven, and more cost effective than traditional hospital-centered care.  
The acknowledgement of this reality has begun to change the approach of some healthcare 
research toward a “p-health” system in which healthcare will become “preventive, 
predictive, preemptive, personalized, pervasive, participatory, patient-centered, and 
precise” [5].  To widen participation, mainstream devices such as smartphones and watches 
have already begun to incorporate systems to encourage healthier lifestyle choices by 
measuring and conveying information to the user pertaining to heart rate, activity level, 
etc. [6].  For more complete care, however, more specialized solutions for out-of-clinic 
monitoring of at-risk individuals must be pursued.  This document will focus specifically 
on research for medical systems based on biomechanical sensing used to monitor joint and 
cardiovascular health with the intent to give healthcare providers the ability to obtain more 
continuous out-of-clinic patient data, provide quantitative feedback for recovery 
characterization, or help monitor and identify early risk factors in at-risk populations. 
1.1 Osteoarthritis 
Osteoarthritis (OA) is the most common chronic joint disease, typically manifesting 
in the hips, knees, and hands of older adults.  Nearly 50% of all adults over the age of 65 
have some form of arthritis, and by 2040 it is estimated that nearly 80 million American 
adults will be diagnosed with the disease – placing an immense burden on the current 
healthcare system [7].  Currently pain is the first symptom which motivates an individual 
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to see their doctor to be assessed for arthritis; however, since articular cartilage is not 
innervated, pain does not typically manifest itself early enough for pharmacological 
treatment to significantly impact the prognosis of the affected individual [8].  While 
additional clinically relevant symptoms of OA differ depending on the joint affected, 
crepitus, joint space narrowing, and stiffness are common to all affected joints such as the 
knee, hip, and hand.  Treatment of OA is usually a combination of physical therapy, non-
steroidal anti-inflammatory drugs or weak opioids, and exercise; severe cases of OA may 
require surgical procedures.  However, the weight loss which results unloading the arthritic 
joint has shown to be the most effective treatment for the OA in the hip and knee [9]. 
The most commonly employed method for OA assessment is X-ray radiology due 
to accessibility, relatively low cost, and ability to view joints in weight-bearing conditions 
[8, 10].  However, continuous monitoring of OA with this method is not sufficiently 
dynamic as it can take more than a year for significant changes in joint space to become 
evident [11-14].  In addition, there are currently no known biomarkers which can aid in the 
early diagnosis of or in determining the prognosis for OA.  If such a biomarker was 
identified, it may provide a more continuous and affordable method for early risk-factor 
identification and recovery monitoring for pre-emptive treatment and quantitative 
classification of recovery for OA. 
The ability to study knee joint acoustics as a biomarker for the severity of and 
recovery from musculoskeletal disease and injury has been shown to provide significant 
potential as a low-cost alternative in proof-of-concept studies [10, 15].  The first part of 
this thesis discusses expansion on the previous work completed by Teague et al [16] to 
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create a more robust and convenient, low-cost method for obtaining and classifying knee 
joint acoustics with a wearable device as a potentially significant biomarker.   
1.2 Cardiovascular Disease 
In 2010, 82.6 million people in the United States suffered from one or more 
cardiovascular diseases (CVD) making it the leading cause of death nationally [17].  
Chronic high blood pressure (BP), known as hypertension, has been clearly identified as a 
significant risk factor for all CVD including coronary heart disease, stroke, heart failure, 
aortic and peripheral arterial disease, and valvular heart disease [18].  While monitoring a 
patient’s BP during clinic visits is an important step in identifying hypertension and CVD 
risk, blood pressure variability (BPV), short term changes in BP, has also been identified 
as a significant risk factor for CVD related mortality but is difficult to measure with current 
devices [19].  In order to track these short term changes, more continuous BP monitoring 
should be performed for at-risk persons.   
The current “gold standard” for blood pressure measurement is intra-arterial 
pressure sensing, requiring the insertion of a pressure transducer into an artery via a 
catheter.  Due to the invasive nature, this method is more commonly implemented during 
surgery and critical care situations [20]. A more commonly accepted method for acquiring 
blood pressure in the clinic is auscultation which is done using a stethoscope, an inflatable 
bladder, and a sphygmomanometer.  Although this method is non-invasive, several 
challenges render it impractical for continuous or semi-continuous out-of-clinic 
monitoring: specialized training is required to perform the test, occlusion of an artery can 
cause discomfort to the subject, and the beat-to-beat BP measurement cannot be found. 
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Automated oscillometric devices are currently available on the market and are capable of 
providing sufficiently accurate BP measurements, but similar to the auscultation method, 
these devices require arterial occlusion and cannot provide continuous BP measurement.  
The use of any occlusive, cuff-based measurement technique has been known to cause 
discomfort, disturb sleep, and be cumbersome for daily use [21]; therefore, a cuffless BP 
measurement system is desired. 
Most current research on cuffless BP measurement systems employ methods based 
on the extraction of pulse arrival time (PAT), the time interval between ventricular 
depolarization and the arrival of blood at a distal location, to estimate BP.  These systems 
attempt to obtain proximal timing references via electrocardiogram (ECG) and distal 
timing references from pulse wave sensors such as photoplethysmogram (PPG) [22, 23], 
electrical bioimpedance (EBI) [24], or epidermal pulse (EP) [25].  While the PAT method 
has been found to correlate well in some studies with systolic blood pressure (SBP), the 
confounding effect of the pre-ejection period (PEP) motivates the need for true proximal 
timing references such as impedance cardiogram (ICG), ballistocardiogram (BCG), or 
seismocardiogram (SCG) instead of ECG [21, 26-30].  The time interval from this proximal 
timing to a distal timing event is then known as pulse transit time (PTT).  The research 
outlined by Kim and Carek et al [26] found that PTT was better correlated with BP than 
PAT for calculating SBP,  diastolic blood pressure (DBP), and mean arterial pressure 
(MAP), calculating r-values of 0.79 and 0.59 (DBP), 0.83 and 0.69 (MAP), and 0.84 and 
0.75 (SBP) for PTT versus PAT respectively.  Similar results were confirmed in other 
studies by Zhang et al [28], Geddes et al [29], and recently by Martin et al [31]. The second 
part of this thesis describes expansion on the previous work outlined by Kim and Carek et 
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al [26] to continue developing systems that utilize the PTT method of deriving beat-to-beat 
BP for continuous or semi-continuous out-of-clinic monitoring.   
1.3 Research Goal 
In addition to the fact that both proposed systems can aid in improving care for a 
number of cardiovascular and joint health complications, they could specifically improve 
quality and cost of care for CVD and arthritis in the growing aging population.  Since CVD 
is the leading cause of death in adults over the age of 65, and more than 50% of this 
population suffers from arthritis, the goal of this research is to develop novel systems which 
will lessen the burden of these diseases on healthcare.  Continuous, out-of-clinic 
monitoring may become increasingly necessary in helping healthcare specialists care more 
completely for a greater number of aging individuals simultaneously by making it possible 





CHAPTER 2. BACKGROUND 
In the beginning of this chapter, relevant background information pertaining to the 
current OA assessment methods, their shortcomings, and the application of joint acoustics 
as a potential biomarker for OA will be presented.  This is followed by a discussion of 
current BP measurement techniques, previous work on cuffless BP estimation via PTT, 
and the biomechanical signals explored in this document for use as proximal and distal 
PTT timing references.  While both OA and hypertension can currently be monitored in-
clinic, such infrequent monitoring does not provide a dynamic understanding of treatment 
effectiveness or condition variability which is essential to providing personalized care.  
With the use of low noise analog electronics and custom front end circuits, wearable 
systems for non-invasive monitoring of OA and BP can be realized to better serve the aging 
population. 
2.1 Osteoarthritis Diagnosis and Monitoring 
OA is the most common joint disorder without an approved treatment method 
currently identified [14]. Joint pain or loss of movement are often the first symptoms which 
lead to an individual being assessed for development of OA [8].  However, these effects 
are usually not noticed by the patient until the disease has already compromised joint 
integrity to the point that pharmacological treatments rarely impact the prognosis.  Invasive 
arthroscopy, the “gold standard” for joint assessment, is not used for early arthritis 
monitoring because of the inherent risk of any surgical procedure, and commonly used 
imaging techniques such as X-ray are only able to detect changes in joint space or articular 
cartilage damage once they are significant [10, 32].  Therefore it would be beneficial to 
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identify bio-markers which can be used to detect the onset of OA earlier in the disease 
progression, and/or quantify treatment effectiveness so that early action, and/or treatment 
modification can be employed to improve the prognosis.  Knee joint acoustics, have shown 
differences in time and frequency domain characteristics in arthritic subjects compared to 
normal knee acoustics during flexion and extension exercises[10, 33], and may prove to be 
a viable means of quantifying early onset and treatment assessment of OA. 
2.1.1 Osteoarthritis Assessment with X-ray and MRI 
During an examination for OA diagnosis, the clinician will passively induce 
movement in the joint of interest.  Observance of crepitus or locking during such movement 
will suggest the presence of osteophytes, which are a primary symptom of OA.  Plain 
radiography is then typically used to confirm the diagnosis.  Although X-ray imaging can 
be used to quickly produce high-resolution images, the ability to quantitatively detect 
changes in joint condition based on this technique typically take at least a year since the 
expected annual joint space decrease due to OA is less than 0.15 mm, but the maximum 
resolution of current radiography technology and procedures is limited to 0.20 mm under 
ideal conditions [13, 14].  This level of accuracy requires many image angles, and between 
image positional standardization that is rarely applied in clinical settings [8].  Despite the 
fact that this procedure is unable to closely monitor the effects of treatment or disease 
progression, it is the only approved method of OA classification [14].  The semi-
quantitative Kellgren and Lawrence grading system is the most widely used classification 
method, and applies a scoring system based on the presence of osteophytes and joint space 




As a result of the highly accurate measurements which can be obtained using 
magnetic resonance imaging (MRI), this method better suited for quantitative analysis of 
OA.  However, MRI is rarely used for clinical diagnostic or monitoring purposes because 
of the long procedure duration (~45 minutes) and high cost ($2,600 on average) [14].  In 
contrast, it is being used in OA research and provides a greater ability to identify osteophyte 
formation, accurate measurement of joint space narrowing, and assessment of soft tissue 
and cartilage integrity. 
 
Figure 1: (A) An X-ray negative of a healthy knee can be easily distinguished from (B) 
an X-ray negative of an arthritic knee.  In the arthritic knee the medial joint space 
compartment is severely narrowed, osteophytes (commonly called bone spurs) are 
present on the femoral condyles and patellar plateau, and a cyst has formed in the patella.  
(A) Open source image from [34]. (B) Used with permission from [35]. 
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2.1.2 Exploring Joint Acoustics as a Biomarker for Osteoarthritis 
Currently there are no available biomarkers apart from the aforementioned imaging 
techniques known to provide relevant information in regard to the diagnosis or prognosis 
of OA [8].    Therefore, because of X-ray radiology’s shortcomings in accuracy, and MRI’s 
duration time and high cost, finding an easily obtainable, affordable biomarker for OA 
diagnosis and monitoring is critical to developing a greater understanding of the 
effectiveness of treatments and early detection of the disease. 
 
Figure 2: An MRI of the knee joint provides the ability to not only visualize the integrity 
of the bone, but also differentiate between soft tissues for assessment of synovial and 
meniscal tissue damage.  Open source image from [36]. 
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Joint acoustics have been investigated since 1902 but have yet to produce clinically 
acceptable results for joint health assessment [37].  However, recent studies by Kim et al 
[10, 33] have been able to demonstrate the ability to discriminate the more frequent, longer 
duration vibrations associated with crepitus in patients with OA apart from the less 
frequent, high frequency clicks present in healthy knees during flexion and extension for 
OA identification.  Observed parameters in these studies include the fundamental 
frequency, jitter, shimmer, energy distribution, energy spread, frequency distribution, and 
frequency spread of knee vibrations between 0.02-2 kHz.  However, work by Teague et al 
[16], and Toreyin et al [38] have shown that there are consistent clicks present in healthy 
subjects’ knees at frequencies as high as 20 kHz during non-weight bearing flexion-
extension and weight bearing sit-to-stand exercises.  Therefore, investigation of a broader 
band of joint vibrations may further improve the ability to distinguish and quantify OA 
based on joint acoustics. 
2.2 Blood Pressure Monitoring for Cardiovascular Health Evaluation 
Hypertension is the most common risk factor assessed for estimation of 
cardiovascular health because of its strong correlation with all other CVDs including 
coronary heart disease, stroke, heart failure, aortic and peripheral arterial disease, and 
valvular heart disease [18].  Therefore, in order to more continuously monitor 
cardiovascular health in the aging population, more continuous blood pressure 
measurement data is needed to provide critical insight needed by today’s clinicians.  While 
monitoring a patient’s BP during clinic visits is an important step in identifying 
hypertension and CVD risk, short term changes in BP, referred to as blood pressure 
variability (BPV), have also been identified as a significant risk factor for CVD related 
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mortality [19].  Automated BP extraction via oscillometry allows for out-of-clinic, semi-
continuous assessment of blood pressure, but these devices are bulky and have been known 
to cause patient irritation due to the occlusive method of BP extraction [21].  In order to 
track these short term changes, without disturbing the individual’s daily life, a more 
continuous, non-occlusive method of BP measurement should be developed for monitoring 
at-risk individuals. 
2.2.1 Blood Pressure Measurement Methods 
Intra-arterial blood pressure measurement is the gold standard blood pressure 
measurement technique due to its ability to provide continuous, direct, beat-to-beat blood 
pressure; thus making it the ideal procedure for patients in critical care situations [20].  The 
method for obtaining this measurement is invasive however, and requires the cannulation 
of an artery.  The cannulation can result in thrombosis, emboli, ischemia, or infection in  
the patient and is only used in-clinic when semi-continuous non-invasive techniques such 
as auscultation and oscillometry are not adequate.  Non-invasive blood pressure 
measurement can be taken by a medical professional through a common technique known 
as auscultation or by an automated oscillometric device.  Both methods utilize an occlusive 
cuff which is inflated to a pressure above SBP and slowly drained to determine SBP and 
DBP.   MAP can then be estimated by equation (1).  The method of auscultation is widely 
accepted in practice and is used for comparison of other BP measurement modalities 
despite the fact that this method may at times compromise accuracy due to inter-observer 
variability and error [39]. 
  
 13 
 Oscillometry is primarily used for semi-continuous BP monitoring for hospitalized 
individuals and may also be used for at-home monitoring [42].  The main advantage of this 
method is elimination of the need for a trained professional to repeatedly perform the 
auscultation method on a patient.  A calibrated oscillometric device is capable of producing 
BP measurements within 15 mm Hg of intra-arterial pressure at least 95% of the time [43], 
but have proved to be less accurate for patients with arrhythmias due to heart rate 
variability, or diabetes, renal failure, and peripheral arterial disease due to changes of 
arterial elasticity [42].  This poses a significant problem for using oscillometric devices for 
monitoring hypertensive patients who are prone to suffer from such comorbidities. 
2.2.2 Non-invasive Cuffless Blood Pressure Measurement 
In order to prevent the need of arterial occlusion, cuffless methods of non-invasive, 




(𝑆𝑆𝑆𝑆𝑀𝑀 − 𝐷𝐷𝑆𝑆𝑀𝑀) + 𝐷𝐷𝑆𝑆𝑀𝑀 (1) 
 
Figure 3: Traditional non-invasive methods are based on occlusive methods which 
require a bulky inflatable cuff.  The auscultation method (A) requires a trained medical 
professional listening for Korotkoff sounds as cuff pressure decreases.  While widely 
accepted, this method has been seen to suffer from inter-observer variability[39].  
Automated oscillometric devices (B) also require an occlusive cuff.  (A) Open source 
image from [40].  (B) Open source image from [41]. 
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surrogate indicator for non-invasive blood pressure estimation is pulse wave velocity 
(PWV) which can be related to blood pressure by the Bramwell-Hill equation (2), a 
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(3) 
Where C is the arterial compliance, P is the pulse pressure, A is the cross sectional area of 
a vessel, and ρ is the blood density in (2), and E is the elastic modulus of a vessel wall, h 
is the thickness of the wall, r is the vessel wall radius, and ρ is the blood density in (3).  
Since PTT is directly related to the length of blood travel, l, and PWV by (4) it can also be 
related to pulse pressure by substituting (4) and (5) into (2) yielding (7), or (4) and (6) into 
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(2), (4), and (5) yield:                  𝑆𝑆𝑀𝑀 =  𝐾𝐾1
𝛼𝛼𝑃𝑃𝑃𝑃
+ 𝐾𝐾2 (7) 
Or (3), (4), and (6) yield:        𝑆𝑆𝑀𝑀 =  𝐾𝐾1 𝑙𝑙𝑙𝑙(𝑀𝑀𝑃𝑃𝑃𝑃) + 𝐾𝐾2 (8) 
Where K1 and K2 are unknown subject dependent variables that must be initially calibrated 
and periodically recalibrated to account for physiological changes such as age related 
arterial stiffening [44].   
Many current cuffless blood pressure estimations use the R-peak of an ECG QRS 
complex as a proximal timing reference [22, 23, 25].  This is due to the fact that the ECG 
signal is robust, well understood, and easily acquired bio-potential signal [30].  However, 
the ECG R-peak value corresponds to ventricular depolarization which proceeds 
ventricular ejection.  The time delay between ventricular depolarization and ejection is 
known as PEP and corresponds to the isovolumetric contraction portion of systole.  The 
problem with including the PEP timing interval for BP estimation is that PEP can be 
influenced by decreased pre-load, increased aortic pressure, or changes in contractility, and 
can negatively correlate with changes in blood pressure [28].  When using ECG as the 
proximal timing reference it is therefore PAT, not PTT, being measured and the pulse 
propagation time can be influenced by changes in PEP by 10-35% [28]. 
Current PTT based BP technologies employ a number of different sensing 
modalities to capture the timing references; for a detailed review of each, and PTT based 
BP estimation overall, the reader is referred to [30].  The particular sensing modalities for 
PTT used in this work were BCG or SCG (as a proximal timing reference) and PPG (as the 
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distal reference). These are discussed below.  ICG, which was used for evaluation of BCG 
and SCG performance as a proximal timing reference is also discussed. 
2.2.2.1 Impedance Cardiogram as a Proximal Timing Reference 
ICG, a form of EBI, is most commonly used for a non-invasive measurement of stroke 
volume, but is also the standard method for non-invasive detection of aortic valve opening 
[30].  The B-point, seen in figure 4, represents the opening of the aortic valve and can 
therefore be used as a proximal timing reference for PTT calculation.  Multiple factors can 
negatively affect EBI/ICG signal quality such as obesity, respiration, and movement [45].  
A thicker layer of subdermal fat will result in an increased baseline thoracic impedance, 
and will also affect the changes in impedance caused by the influx of blood into the aorta 
[46].  While respiratory and motion artifacts can be mitigated or filtered for improved 
EBI/ICG accuracy, obesity cannot be mitigated and is a common comorbidity in 
hypertensive and pre-hypertensive individuals; thus reducing the robustness of this 
measurement technique for cuffless blood pressure estimation in the target population. 
2.2.2.2 Ballistocardiogram as a Proximal Timing Reference 
BCG is a measurement of the reactionary forces of the body to the acceleration of 
blood being ejected from the left ventricle into the ascending aorta, and the subsequent 
movement of blood through the arterial tree.  The maximum amplitude of the BCG signal 
can be as small as 1-7 mg but is sufficient to be measured by many commercially available 
accelerometers, strain gauges, and load cells integrated into bathroom scales, hospital beds, 
chairs, and wrist worn devices [47, 48].  Of the H-, I-, and J-waves which can be observed 




Figure 4: ICG, BCG, and SCG can serve as proximal timing references for PTT 
calculation.  When ECG is implemented as the proximal timing reference the result is 
PAT which includes the PEP.  Names of pertinent waveform features are shown. 
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as it has been associated with aortic valve opening based on a recently published model of  
the mechanism of the BCG signal [31].  The movement associated with BCG can be seen 
in all three anatomical planes, but the longitudinal displacement (head-to-foot) is the most 
commonly studied signal.  The largest obstacle encountered when using BCG as a proximal 
timing reference for BP estimation are subject motion artifacts occurring during 
measurements.  The BCG signal bandwidth range is limited from dc-40 Hz and should be 
bandpass filtered in both hardware and software to remove motion from the signal to the 
extent possible. 
2.2.2.3 Seismocardiogram as a Proximal Timing Reference 
SCG is the signal corresponding to the motion of the chest wall during the cardiac 
cycle and is sensed by simply placing an accelerometer against the chest to monitor the 
vibrations [47, 49].  Both the cardiac and pulmonary cycles will cause motion of the chest 
wall, but the motion resulting from the pulmonary cycle is at a much lower frequency than 
the cardiac related vibration and can readily be filtered from the signal.  As can be seen in 
figure 5, the SCG waveform can be used to determine the time of aortic valve opening and 
can therefore serve as a proximal timing reference for PTT measurement.  Preliminary 
studies have used the aortic valve opening feature found in SCG as the proximal timing 
reference, but rapid ejection may also be sufficient [27].  It should be investigated as to 
which timing reference correlates more strongly with changes in BP. 
2.2.2.4 Photoplethysmogram as a Distal Timing Reference 
PPG sensors are used clinically to non-invasively monitor the oxygen-hemoglobin 
saturation of pulsatile blood (SpO2), and can also be used to determine other cardiovascular  
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features such as heart rate and change in pulsatile blood volume in a given tissue location.  
PPG can be measured by using a combination of one or more light-emitting diodes (LEDs) 
with one or more photodiodes (PDs) in either transmissive or reflective orientation.  The 
intensity of light captured at the PDs is therefore a measurement of the amount of light 
transmitted through or reflected back from the illuminated tissue.  While the dc component 
of the PPG signal is based on the structural makeup of the illuminated tissue, the ac 
component is able to provide information about changes in blood volume in the illuminated  
area because of the Beer-Lambert law for light absorption in a given medium given by 




� = −𝜀𝜀 ∙ 𝐶𝐶 ∙ 𝑃𝑃 
(9) 
 
Figure 5:  The PPG signal can be detected in either the transmissive or reflective mode.  
The change in emitted LED energy delivered to the photodiode is caused by the changes 
in blood volume due to the high absorption rate of hemoglobin.  In addition to pulse 
detection, PPG can be used to detect heart rate, respiration rate, and transmissive PPG 




Where I(t) is the intensity of light transmitted through the medium, I0 is the intensity of the 
source, ε is the absorption coefficient of the medium, C is the concentration of the 
chromophore, and V is the volume.  Since hemoglobin is highly absorptive to the 
wavelengths of light used in PPG sensors, an increase in blood volume in the illuminated 
area causes less light to be either reflected or transmitted through the tissue which can be 
used to find heart rate or pulse volume.   
To use PPG as a timing reference for PTT calculation, either green, red, or IR LEDs 
can be used.  Because green has the shortest wavelength it is more robust to motion 
artifacts, but is unable to penetrate past skin depth [50].  Since changes in the 
microvasculature of the skin can be dramatically affected by temperature, it is not 
recommended to use a green LED for PTT timing reference.  In addition, transmission 
mode PPG is limited by the penetration depth of the LED and is only usable at distal sites 
including the fingers, toes, or earlobe where blood flow is also more sensitive to 
environmental temperature and neural modulation than larger arteries, making reflectance 
mode PPG more suitable for PTT timing reference determination at sites including the 
wrist, dorsum of the foot, or forehead [30].  PPG can be negatively affected by motion 
artifacts and changes in contact pressure during measurement, but is a high quality and 




CHAPTER 3. DESIGN, SIGNAL PROCESSING, AND METHODS 
3.1 Joint Sound Recording Instrumentation and Physical Design 
This project began with improving the previously used joint sound recording 
system [16] performance by implementing the system in a wearable, untethered design and 
improving the measurement methods by creating an ultra-low noise AFE pre-amplifier.  
The joint sound recording system will be designed to record joint sound data using two 
piezo-ceramic contact microphones, BU-23173, as well as joint angle data from two digital 
three axis accelerometer & gyroscope IMUs, LSM6DS3,  corresponding to the acoustical 
emissions of the knee.  A block diagram of the system architecture can be seen in figure 6.   
3.1.1 Analog Front End Design for Joint Sound Recording 
In order to obtain high quality acoustical signals from the knee joint with the contact 
microphone, an AFE was designed for low noise amplification and filtering of the output 
signal.   Radio frequency interference (RFI) and DC offset is removed from the signal 
before the gain stage of the AFE by use of a second order 8 MHz LPF cascaded to a 
0.159 Hz first order high pass filter (HPF).  The following gain stage has a manually 
selectable gain, operated by a single pole double throw (SPDT) switch, of 20 or 40 dB with 
a 16 Hz HPF on the output.  The last stage of the AFE includes a 6th order Butterworth 





Figure 6:  Block diagram of the joint sound recording system architecture which is 
comprised of two electronics boxes and two Knowles contact microphones. 
When designing the front end, the IC selection played a critical role in fulfilling the 
ultra-low noise requirement for the given application.  The amplifier used in the gain stage 
of the AFE is an LTC6240 (Linear Technology, Milpitas, California) with an 18 MHz gain 
bandwidth product (GBWP).  Therefore, even at the voltage gain setting of 100, the 
amplifier can support a 180 kHz bandwidth, nine times greater than the filter cutoff 
frequency in the front end.  In addition, the IC has a mere 7 nV/√Hz resulting in ~1 µVRMS 
in band noise at the input, and ~100 µVRMS at the output.  The LTC6257 used in the filter 
stage has a 20 nV/√Hz noise per amplifier, resulting in an added ~8.5 µVRMS at the output 




Figure 7:  The circuit schematic containing the gain and filter stage design of the AFE.  
Not shown in the diagram is the voltage regulator IC which sets the 3 V output used for 
powering the amplifiers and microphone, as well as set the midpoint voltage used to bias 
the input signal in the single supply design. 
The AFE was created in LTSpice (Linear Technology, Milpitas, California) and 
simulated for verification of design.  Once the design was confirmed, a PCB board layout 
was designed using EAGLE (CadSoft, Guelph, Ontario) to develop a set of Gerber files.  
All of the resistors and capacitors, except for the 10µF tantalum capacitors, were selected 
to be 0402 surface mount package and the 10µF tantalum capacitors were selected to be 
0603.  Once the PCB was assembled, the AFE pre-amplifiers were characterized using a 
SR785 Dynamic Signal Analyzer (Stanford Research, Stanford, California). The 








































































step response, and noise floor of the AFE.  The results from the characterization can be 
seen in Chapter IV. 
3.1.2 Wearable System Implementation 
The primary electronics box is a Bud Industries (Willoughby, Ohio) CU-341-A and 
houses the STM32F405 microcontroller board, the accompanying breakout board 
connected via 32 conductor flex cable, two microphone pre-amplifier circuits, one 6-degree 
of freedom IMU, and one 850 mAh polymer lithium ion battery (figure 8.A).  The front 
panel of the primary box includes two TB3M XLR connectors for connecting to the 
microphones, one TB6M XLR connector for connecting to the IMU box, one green LED 
for power up and data recording notification, one red LED for recording error notification, 
one momentary pushbutton for toggling the microcontroller in and out of standby mode, 
one single pole slide switch for data recording start and stop, and one double pole slide 
switch for controlling the destination of the microphone data (figure 8.C).  During data 
collection, the microphone data must be directed to the microcontroller from the pre-
amplifier circuits; however, it may be beneficial for the investigator to have the ability to 
bypass the microphones and directly listen to the microphones.  This bypass ability can aid 
in determining optimal microphone placement thereby improving the system performance.  
When placed in the “bypass” position the double pole switch can direct both pre-amplifier 
signals to a single pole slide switch located on the back panel of the primary box.  This 
single pole slide switch is used to route the signal from the individual pre-amplifiers to a 
1/8” four conductor female audio connector also located on the back panel (figure 8.D).  






Figure 8:  An image of the primary electronics box (A), IMU box (B), primary box front 
panel (C), and primary box rear panel (D).  Also shown is a front view (E) and side view 







second 6- degree of freedom IMU (figure 8.B).  The front panel of the IMU box includes 
one TB6M XLR connector for connecting to the primary box. 
In order to interface with the subject, flexible mounting units were created to attach 
the primary box to the lateral side of the subject’s thigh and the IMU box to the lateral side 
of the subject’s shank.  The straps used to suspend each mounting unit were created using 
Stretchrite 1-1/2” heavy stretch elastic knit and a Strapworks 1-1/2” plastic slide.  The 
mounting units were printed in Ninjaflex flexible filament from NinjaTek.  This wearable 
system can be used for untethered joint sound recording for studies during complex (e.g. 
pivoting, stair climbing, etc.) movements to analyze knee joint sounds in healthy and 
injured knees. 
3.2 Cuffless Blood Pressure Design, Signal Processing, and Methods 
3.2.1 Utilizing BCG and PPG for PTT Timing References 
Work on the cuffless BP measurement system began by assisting A. Carek to 
assemble a modified bathroom scale prototype for measuring PTT.  This device was similar 
to the system previously described by our group in [26]; however, in addition to measuring 
BCG as a proximal timing reference, the new prototype also included a Velcro foot-strap 
utilizing a single reflective PPG sensor to measure a distal pulse timing reference from the 
dorsalis pedis artery.  With correct sensor placement, PTT could be captured as the time 
delay between the BCG I-wave and the foot of the arriving pulse waveform measured at 
the distal PPG sensor. 
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3.2.1.1 Modified Bathroom Scale to Measure BCG 
BCG was measured using a modified weighing scale as seen in [51]. Four load cells 
at each corner of the scale are configured as a Wheatstone bridge.  The scale used for the 
measurement is a BC-534 InnerScan Body Composition Monitor (Tanita, Arlington 
Heights, Illinois).  The custom AFE used in the design inputs the differential voltage across 
the bridge to an instrumentation amplifier with a 54 dB gain, followed by a 0.5-24 Hz 
fourth order bandpass filter and a 35.5 dB gain [51]. 
3.2.1.2 Modified PPG Sensor Array 
A key limitation of the design was that by only using a single PPG sensor the distal 
measurement was sensitive to placement error, and the sensor would often need to be 
moved several times before a reliable distal pulse waveform could be captured.  This issue 
would likely be accentuated if the device were to be used by an individual unfamiliar with 
the anatomical structure of the foot.  Therefore, in order to improve the robustness of the 
distal pulse detection despite variations in sensor placement or user knowledge of foot 
anatomy, as well as account for anatomical differences between individual users, an array 
of PPG sensors was constructed.  The new sensor included an array of three PPG sensors 
incorporated into a sandal with an adjustable foot strap as seen in figure 9.A.  In addition 
to modification of the PPG sensor design, a software program was created to process the 
output of each PPG sensor in the array and classify waveform as either high or low quality.  
Once classified, only high quality signals would be used to constitute the distal waveform 
for beat-to-beat PTT calculation. 
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The improved distal PPG sensor array was designed using a combination of three 
PPG sensors as seen in figure 9.A.  The array utilizes a single 5 V line to reverse bias three 
photodiodes per sensor (S2386-18k, Hamamatsu Photonics, Shizuoka, Japan), placing the 
diode in the photoconductive mode, and to power the one red LED per sensor (L6112-02, 
Hamamatsu Photonics).  This diode was selected due to its extremely low dark current of 
a maximum of 2 pA when a 10 mV reverse bias voltage is applied.  The connected anodes 
of the three photodiodes in each PPG sensor are connected to the input of an individual 
channel of a custom AFE created by A. Carek (figure 9.B). Aligning the three photodiodes 
in parallel sums the currents together, reducing zero-mean noise.  Each photodiode is 
photosensitive at a rate of 0.6 A/W of delivered energy.  The current generated by each 
sensor channel is wired on the printed circuit board (PCB) to the negative terminal of an 
LT1678 (Linear Technology, Milpitas, California) which is arranged as a transimpedance 
amplifier (TIA).  The AFE includes a 300 kΩ resistor in parallel with a 68nF capacitor for 
each TIA feedback loop.  The resistor sets the transimpedance gain and dynamic range of 
the amplifier while the capacitor is used to reduce the gain of any out of band frequency 
feedback from the op amp which may result in oscillation; the passband cutoff of the RC 
feedback is ~8 Hz.  Since the TIA is powered with a 5 V single supply, and the signal is 
referenced to a midpoint voltage of 2.5 V, the 300 kΩ resistor will cause the TIA to rail at 
currents exceeding ±8.33 µA.  The voltage output of the TIA is then filtered through a filter 
stage which employs a two stage filter with 60 dB gain made up of an inverting bandpass 
filter in the first stage followed by a non-inverting Sallen-Key bandpass both with a ~0.8-




Figure 9: (A) The improved PPG array integrated into an adjustable Velcro sandal strap 
including 3D printed mounting fixtures for the LEDs and photodiodes in each sensor. 
(B) The PPG AFE developed by A. Carek. (C) The circuit schematic for the PPG array 
including the array, AFE, and digital potentiometer. 
The L6112-02 LEDs used in the PPG sensors have a typical forward voltage drop 
of 1.8 V and produces a radiant flux of 2.5 mW with a 20 mA excitation current.  Due to 
anatomical differences between the thickness and makeup of subdermal tissue between 
subjects’ feet, the amount of light produced by a LED can negatively affect the output PPG 
signal, even when placed in the correct location, by either causing oversaturation of the 
photodiode TIA or not producing enough energy to obtain a defined pulse waveform from 
reflected light.  Therefore, a digital potentiometer was added in series with the three parallel 
LEDs.  This feature enables an easily adjustable control of the amount of current drawn 
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through the LEDs between data acquisitions.  The series combination of the selected 
potentiometer, X9C102S (Intersil, Milpitas, California), and the 75 Ω input resistor to each 
LED have a total resistance range from 85-1075 Ω.  With this range of resistance, current 
through each LED can be modulated between 3 and 38 mA.  Therefore, the power 
consumption of each LED can range from 5.4 to 68.4 mW, allowing for simultaneous 
optimization of the system’s power consumption and signal quality. 
3.2.2 Quality Classification of PPG Signals 
Upon testing the improved PPG sensor array, it was quickly discovered that the 
difference in position of the three sensors commonly resulted in a non-ideal placement of 
at least one sensor no matter where the array was positioned. The noise generated from the 
misplaced sensor tended to dominate the physiological signal, deteriorating the signal-to-
noise ratio and making distal timing extraction difficult. Therefore, it was deemed desirable 
to be able to automatically determine the quality of a PPG signal detected from a particular 
sensor, and exclude any sensor data with a low-quality output.  A classification algorithm 
was created using supervised machine learning based on features extracted from data taken 
using the PPG array. 
3.2.2.1 Data Collection for Test-Set 
Six-minute long recordings of PPG waveforms were collected from three subjects 
using the PPG array placed on the dorsum of each subject’s right foot.  Each PPG sensor 
in the array was connected to a channel of the custom AFE.  The output of each channel 
was sampled at 2 kHz using three analog input channels of a BIOPAC MP150 (BIOPAC 
Systems Inc., Goleta, California) UIM100C universal interface module with the associated 
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AcqKnowledge 4.2 data acquisition and analysis software.  At the conclusion of each six-
minute recording, the data was saved as a MATLAB (MathWorks, Natick, Massachusetts) 
data file (.mat).  During the recordings, two of the subjects were instructed to stand in a 
still position in an attempt to reduce motion artifact corruption of the signals.  One subject 
was instructed to sway for twenty seconds of the recording.  Each of the recordings was 
then parsed into four-second long intervals and plotted using MATLAB.  By visual 
inspection, each of the 270 four-second long recordings was classified as either high-
quality (1) or low-quality (-1).  The high quality PPG signals appear as periodic waveforms 
with minute variation between each beat with a clearly distinguishable foot and peak of 
each arriving pulse.  Additionally, the foot and peak amplitudes are consistent from beat-
to-beat and the signal is not clipped by the supply rails.  After the recordings were 
classified, the classification values were stored in a vector and used to develop a supervised 
learning model for PPG quality classification.  
3.2.2.2 Feature Extraction 
In collaboration with A. Carek, time and frequency domain features were then 
extracted to be used in the supervised learning process.  Forty-five features were created in 
four different LabVIEW virtual instruments (VIs).  A LabVIEW VI was then created by 
A. Carek to produce a spreadsheet of all forty-five feature outputs based on the 270 
recordings.  A supervised logistic regression with ten-fold cross-validation was performed 
on the extracted feature data using Weka (The University of Waikato, Hamilton, New 
Zealand), a logistic regression modeling program, and the classification vector.  A ranked 
search was used to evaluate  the features based on each feature’s ability to predict correct  
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 classification of the test set [52].  It was determined that lowest performing features were 
overfitting the model and were therefore removed from the regression.  This process was 
repeated until the removal of the lowest performing feature no longer improved the 
performance of the classifier on the test set.  A total of eleven features were removed, 
leaving thirty-four features to be used in the development of the classification coefficients 
 
Figure 10:  Example of a time (A) and frequency (B) domain PPG recordings of a low-
quality PPG signal due to poor sensor placement.  A high-quality time (C) and frequency 
(D) PPG signal includes more consistent peak height, periodic peak timing, and clearly 
defined frequency harmonics due to the periodicity of the signal. 
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and bias.  The performance of the PPG quality classification algorithm is detailed in 
Chapter IV. 
3.2.2.3 User Interface 
The finalized classification coefficients were added into an array in the LabVIEW 
VI which incorporates a user interface (UI) design, the feature extraction, and classification 
of the PPG signals.  The VI was implemented on a myRIO embedded hardware device, to 
which the BCG scale output and PPG sensor array outputs were connected.  Upon receiving 
the start command from the UI front panel, four-seconds of PPG data is recorded 
simultaneously from each of the three PPG inputs.  The feature extraction VIs would then 
calculate the thirty-four features from each PPG channel sample and store them in separate 
arrays.  Next the classification coefficients were applied to the extracted features and the 
bias was removed.  The sign of each result determines the signal classification, with a 
negative output representing the detection of a high-quality signal, and positive 
representing a low-quality signal. 
The user was informed if no quality PPG signals were obtained during the initial 
sample, and another four-second sample would immediately be taken from the sensors for 
re-evaluation.  If PPG signals remained low-quality for several evaluations, the PPG strap 
pressure and position could be adjusted until a quality signal was found.  If one or more 
quality signals were obtained during the four-second recording sample, the VI would begin 
plotting the real time recording of PPG and BCG signals in separate plots on the user 
interface.  The output PPG data plotted would be the sum of the high-quality PPG 
waveforms.  At this point, the recording could be stopped at any time and cursors on the 
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plots could be manually positioned at the I-wave of the BCG signal and the foot of the PPG 
pulse wave of the same beat.  The time difference between these two references represents 
the PTT associated with that beat.  PTT could similarly be calculated for each beat in the 
recording which would allow for continuous beat-to-beat estimation of blood pressure 
based on equation (8).  Values of K1 and K2 need to be calibrated for each individual for 
the estimation.   
3.2.3 Seismocardiogram Implemented as a Proximal Timing Reference 
Although the BCG-PPG based system is capable of continuously measuring beat-
to-beat PTT and, therefore, allows for estimation of beat-to-beat BP, design improvements 
were desired to realize a wearable system implementation of PTT measurement.  It was 
decided that SCG would be pursued as a proximal timing reference in a watch based 
system, with a wrist based PPG implemented into the backside of the watch face as a distal 
timing reference.   
3.2.3.1 Accelerometer Selection 
A low noise accelerometer, LIS344ALH (STMicroelectronics, Geneva, 
Switzerland), was chosen to measure the chest wall vibrations which compose the SCG 
signal.  The accelerometer has a sufficiently low noise density level of 50 µg/√Hz for the 
SCG measurement.  On each axis of the accelerometer a 110 kΩ output resistor is in series 
with the output signal inside the device.  A single pole low pass filter with a cutoff 
frequency of ~66 Hz was implemented at the Z-axis output by adding a 22 nF capacitor to 
ground.  With this bandwidth, and a single pole low pass filter (LPF), the approximate 
RMS noise of the sensor can be calculated as seen in equation (10).  The peak-to-peak 
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noise can then be assumed to be within 6.6 standard deviations of the RMS noise 99.9% of 
the time (11).   
𝑁𝑁𝑅𝑅𝑅𝑅𝑅𝑅 ≅   1.57 ∙ 𝑁𝑁0 ∙ √𝑆𝑆𝑃𝑃  (10) 
𝑁𝑁𝛼𝛼−𝛼𝛼 ≅  6.6 ∙ 𝑁𝑁𝑅𝑅𝑅𝑅𝑅𝑅 (11) 
This results in a 4.2 mgp-p referred to the input (RTI) sensor noise; one-fifth of the expected 
20 mgp-p SCG vibrations.  In addition, when powered by a 3 V source the accelerometer 
has a 0.6 V/G sensitivity.  Therefore, the expected output will be 12 mVp-p, which can be 
sufficiently measured by the 16-bit, ±10 V ADC in the BIOPAC MP150 which has a 
0.3 mV specificity. 
3.2.3.2 Proof of Concept 
Testing was performed to determine the feasibility of using the LIS344ALH 
accelerometer for SCG detection.  The preliminary tests included characterization of the 
robustness of the sensor measurement against differences in contact pressure between the 
sensor and the sternum, as well as robustness against user placement error by taking SCG 
measurements at different locations along the sternum and thoracic cage. All studies were 
approved by the Georgia Institute of Technology Institutional Review Board.  
To characterize the measurement robustness against contact pressure and 
placement error, four subjects were recruited and SCG data was recorded from each subject 
with the LIS344ALH accelerometer.  A FS20-0000-1500-G (Measurement Specialties, 
Hampton, Virginia) low force compression load cell was used to determine effects of  
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 contact pressure by measuring the applied force the subject exerted on the accelerometer 
as it was positioned on the sternum.  To evaluate positional placement effects, SCG was 
recorded from seven different positions over a thin article of clothing (e.g. a t-shirt) 
between the accelerometer and the skin: position one located at the xiphoid process, 
position five being slightly inferior to the suprasternal notch, and positions two, three, and 
four evenly spaced between them as seen in figure 11.A.  Position six was eight to ten 
centimeters left of position one, and position seven eight to ten centimeters right of position 
one.  Finally an eighth recording was taken at position three except this recording was taken 
with the accelerometer making direct contact with the skin (i.e. clothing article removed).  
At each position, SCG was recorded using BIOPAC MP150 UIM100C and associated 
AcqKnowledge data acquisition software for three twenty-second intervals at the specified 
force gradient.  With the load cell placed on the back of the accelerometer, subjects were 
 
Figure 11: (A) The eight positions used to test the robustness of the SCG measurement 
to placement error.  Positions 1-3, and 8 produced consistent results for PEP extraction 
between the subjects.  (B) An example of the robustness test with the load cell pressed 
into the accelerometer which was placed against the chest at each position. 
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asked to hold the accelerometer in place by exerting forces of 125, 375, and 625 grams, 
correlating to a light, median, and hard press (figure 20).  In addition to SCG, ECG was 
recorded using the BIOPAC BioNomadix 3-lead wireless ECG transmitter.  All data was 
saved as MATLAB data files for processing. 
First, each set of recorded data was parsed into beats using the ECG R-peak as the 
starting reference of each beat by R-peak detection algorithm.  Once each beat had been 
parsed, the aortic opening (AO) feature of the SCG signal was extracted from each beat.  
For each subject, the R-peak of the ECG to the AO of the SCG (R-AO) interval was 
compared between each of the eight evaluated positions and between each of the applied 
pressures.  The results of this comparison are detailed in Chapter IV. 
3.2.3.3 Extracting PEP with a Watch Based Prototype 
In addition to characterizing SCG robustness in the proof of concept study, the 
accuracy with which the watch-based SCG prototype could capture the AO point was 
assessed.  Specifically, PEP (R-AO) measurements using the SCG based system were 
compared with simultaneously recorded results from the ICG (R-B).  Since it is well 
documented that PPG can serve as a distal timing reference for PTT, a strong correlation 
between SCG and ICG would provide an important step towards validating the system’s 
use for obtaining quality PTT measurement.  A watch based prototype was developed using 
the LIS344ALH accelerometer inserted into the 3D printed watch face for SCG 
measurement, and two IR LEDs, VSMF2893GX01 (Vishay Intertechnology, Malvern, 
Pennsylvania), combined with two S2386-18k photodiodes for PPG measurement at the  
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palmar side of the wrist.  The prototype PPG output was wired to the PPG AFE described 
previously, and the Z-axis of the SCG measurement was wired to a perforated board and 
stabilized across a 10 nF capacitor to ground.  In addition, the wires in the cable were 
shielded to reduce any RFI.  The finished prototype can be seen in figure 12.   
Three subjects were recruited and measurements were taken from positions 1-3 
(positions described in the previous study) using the prototype by firmly pressing the watch 
face against the sternum at the specified locations.  SCG and PPG signals measured using 
BIOPAC analog input channels.  ECG and ICG were also recorded during the study using 
BioNomadix 3-lead wireless ECG transmitter and BioNomadix wireless NICO (non-
invasive cardiac output) 8-lead ICG transmitter.  Data collection from each position began 
with the subject standing at rest for thirty seconds.  After the thirty second resting 
 
Figure 12:  The watch prototype including the LIS344ALH low noise accelerometer (1), 
the VSMF2893GX01 IR LEDs (2), and the S2386-18k photodiodes (3) used to detect 
SCG-PPG based PTT for blood pressure estimation.  The current prototype is 




recording, the subject performed a fifteen second Valsalva maneuver followed by one 
minute of recovery recording. All the recorded data was saved in AcqKnowledge in 
MATLAB data files for processing.  The ability of the acquired SCG signal to serve as a 
proximal reference was then compared to the ICG measurement by evaluating the 
correlation of changes in PEP measured using the different modalities (R-AO of SCG vs. 
R-B of ICG).  The results of this correlation are detailed in Chapter IV.  PPG data recorded 
using the prototype was not used for this portion of the study. 
Next, eight subjects were recruited to further evaluate the performance of the 
prototype by correlating the changes in SCG based PEP with changes in ICG based PEP 
after exercise.  The same systems were used for this study as the previous study.  SCG, 
PPG, ECG, and ICG data was recorded at rest for one-minute.  Next, the subject performed 
one-minute of intense exercise; no data was recorded during the exercise phase.  After the 
exercise, a five-minute recovery recording was taken as the subject’s heightened heart rate 
returned to the resting state.  All the recorded data was saved in AcqKowledge in MATLAB 
data files for processing.  MATLAB was then used to correlate changes in PEP found 
between SCG and ICG as detailed in the previous study description.  The results of this 
correlation are detailed in Chapter IV. 
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CHAPTER 4. RESULTS 
4.1 Joint Sound Recording System Results 
4.1.1 AFE Characterization 
The AFE, seen in figure 15, was characterized using the SR785 to test the frequency 
response (figure 16), total harmonic distortion (figure 17), dynamic range (figure 18), and 
noise floor (figure 20).  The step response (figure 19) was characterized using an Agilent 
Technologies 33500B True Waveform Generator and Agilent Technologies MSOX-3024A 
oscilloscope.  The characterization results can be seen in the following figures. 
 
 
Figure 13:  The pre-amplifier AFE designed for joint sound recording with the Knowles 







Figure 14: The magnitude (dB) and unwrapped phase (degrees) outputs from the 
frequency response sweep performed from 10 Hz to 100 kHz with the circuit set to 
voltage gain of ten (top) and 100 (bottom).  The passband gain is 19.7 dB with -3 dB 
bandpass cutoff frequencies is at 57.6 Hz and 21.4 kHz for the ten voltage gain setting.  
The passband gain is 39.0 dB with -3 dB bandpass cutoff frequencies is at 59.3 Hz and 
20.9 kHz for the 100 voltage gain setting.  The test was performed by using the SOURCE 
channel on the signal analyzer as the input to CH1 on the analyzer and the MIC IN of 
the AFE with the V OUT of the AFE being connected to CH2 of the analyzer.  A swept 
sine from 10-100 Hz was input to the system with a 10 mVRMS and 1 mVRMS amplitude 







Figure 15:  The total harmonic distortion of the circuit was measured by inputting a 
10 mVRMS and 1 mVRMS amplitude 1 kHz signal from the SOURCE of the analyzer to 
the MIC IN of the AFE at the voltage gain ten (top) and 100 (bottom) settings.  The THD 
was measured at the output of the AFE on CH1 to be 0.0122% for the voltage gain ten, 






Figure 16:  The dynamic range of the AFE was measured by performing the same THD 
test on the circuit and increasing the RMS voltage of the input 1 kHz signal until the 
THD output reached 10% of the input value.  For the voltage gain ten setting (top) this 
occurred when the input signal amplitude had been increased to 123.4 mVRMS, and 






Figure 17:  The step response of the AFE was measured by inputting a 2 kHz step 
function using an Agilent Technologies (Santa Clara, California) 33500B True 
Waveform Generator with a 20 mVP-P for the voltage gain ten setting (top) and 2 mVP-P 
for the voltage gain 100 setting input into the MIC IN of the AFE.  The output was 
measured and recorded using an Agilent Technologies MSOX-3024A oscilloscope.  For 
the voltage gain ten setting the rise time of the AFE was 24 µs, the settling time was 118 
µs, and the overshoot was 32.0%.  For the voltage gain 100 setting the rise time was 23.8 





Figure 18: The maximum AFE noise characterization was performed in the voltage gain 
100 setting with the microphone connected (microphone and circuit noise) and 
unconnected (circuit noise only).  With the microphone connected and wrapped in 
Blu Tac (Loctite, Dusseldorf, Germany) to shield the microphone from external noise 
the output was connected to CH1 of the signal analyser.  The noise was largely 
dominated by the microphone until the 20 kHz cutoff frequency was reached and the 
system noise became dominated by the white noise of the circuit.  A spike in system 
noise can be seen at 9.87 kHz which is due to the ~10 kHz resonate frequency of the 
contact microphone specified by the manufacturer.  The A-weighted noise calculated 
with the microphone attached to the circuit is also plotted.  The circuit noise was obtained 
by adding a 5 kΩ resistor to ground to match the microphone output resistance at the 
XLR connector and connecting the AFE output to CH1 of the signal analyzer.  The noise 
of the circuit is 18 nV/√𝐇𝐇𝐇𝐇 throughout the passband, and is negligible when compared 
to the microphone noise. 
4.2 Cuffless Blood Pressure System Results 
4.2.1 Quality Classification of PPG Signals 
Using the 10-fold cross validation method, the classification algorithm was able to 
correctly classify 92.8% of the 270 four-second long PPG recordings.  Next, another 
twenty-four minutes of PPG data was recorded from two subjects using the improved array 
resulting in an additional 360 four-second long PPG segments.  This data was used to verify 
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the classification algorithm by testing its performance on untrained data.  The algorithm 
correctly classified 88.9% of the untrained validation set.  The performance of the 
classification algorithm is further discussed in Chapter V. 
4.2.2 SCG Robustness against Position and Pressure Gradient 
The method of quantifying the robustness of the LIS344ALH accelerometer as a 
means of obtaining SCG as a proximal timing reference for PTT is described in section 
3.2.3.2.  The collected data was then imported into MATLAB where a function was created 
to extract the time reference of the AO point from the SCG signal for each beat.  First, the 
beats were parsed using the ECG R-peaks.  The timing of each R-peak also represented the 
start of the PEP for every beat.  Using the extracted AO feature, the difference in PEP 
found at positions 1-3, and the effect of the 125-625 gram pressure gradient for three of the 
four subjects is shown below in table 1 and figure 21.  SCG from the omitted subject was 
extremely compromised by effects of hand tremors and consistent SCG AO peaks could 
not be obtained.  This is further discussed in Chapter V. 
 
Subject # Contact Force AVG PEP PEP STD 
1 125 g 30.77 ms 1.49 ms 
1 375 g 31.77 ms 2.77 ms 
1 625 g 28.50 ms 1.87 ms 
2 125 g 20.03 ms 2.99 ms 
2 375 g 18.53 ms 2.88 ms 
2 625 g 18.75 ms 3.08 ms 
3 125 g 47.21 ms 1.66 ms 
3 375 g 47.47 ms 1.92 ms 
3 625 g 46.16 ms 1.84 ms 
Table 1: The average and standard deviation of the PEP found from positions 1-3 based 
on the applied force gradient of 125, 375, and 625 grams from three subjects.  PEP was 
found using the ECG R-peak and AO feature of the SCG captured using the LIS344ALH 





Figure 19: (Top) The plotted effect of contact pressure at positions 1-3 is minimal in the 
PEP detection using the LIS344ALH as a means of obtaining SCG.  The standard 
deviation of average PEP found between the three pressures is 1.67 ms for subject 1, 
0.81 ms for subject 2, and 0.69 ms for subject 3.  (Bottom) A plot showing the minute 
changes in SCG waveform from subject 1 over the pressure gradient. 















Using the extracted AO feature, the PEP found at each position was normalized 
based on position 1 for three of the four subjects.  The normalized PEP at each position can 
be seen in table 2 and figure 22.  The results are discussed further in Chapter V. 
Subject # Pos 1 Pos 2 Pos 3 Pos 4 Pos 5 Pos 6 Pos 7 Pos 8 
1 1 0.87 0.80 0.95 1.27 0.76 2.08 0.92 
2 1 0.72 0.80 1.29 1.87 0.81 2.38 1.07 
3 1 0.99 0.96 0.88 1.02 0.53 1.39 0.93 
 
Table 2: The average PEP found at each position was normalized based on the PEP found 
at position 1.  The normalized data for each subject at each position is included below. 
 
Figure 20:  The average normalized PEP at each position from the three subjects.  
Positions 1, 2, and 3 are very consistent with one another and the standard deviations at 
position 2, 3 and 8 are 0.13, 0.09, and 0.088 respectively across the three subjects. 
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4.2.3 ECG-SCG Correlation with ECG-ICG PEP 
As detailed in section 3.2.3.3 the correlation of SCG detected PEP was compared 
with ICG detected PEP.  The results can be seen below in figure 23.  The results are further 
discussed in Chapter V. 
  
 
Figure 21:  The correlation between changes in SCG detected PEP and ICG detected 
PEP following Valsalva can be seen for the three subjects used in the study.  The R2 
values and relating equation between the R-B interval and R-AO interval are also shown. 
 












R 2  = .74
(R-B) = 2.7*(R-AO) + 14.6













R 2  = .89
(R-B) = 2.3*(R-AO) + 26.3












R 2  = .76




Figure 22:  The individual correlations between changes in SCG and ICG detected PEP 
following exercise can be seen for the eight subjects in the study.  The R2 values and 





Figure 23:  The correlation results for all eight subjects combined between changes in 
SCG and ICG detected PEP following exercise can be seen.   The R2 value and relating 






CHAPTER 5. DISCUSSION 
Design considerations for the joint sound recording and cuffless BP measurement 
systems were focused on capturing clinically relevant data with wearable systems for more 
frequent out-of-clinic monitoring.  Such systems may play a critical role in the 
development of preventative healthcare, which would greatly reduce cost and improve 
effectiveness of care compared to the current hospital based system. 
The developed joint sound recording system could be used to continuously record 
knee joint acoustics in- or out-of-clinic at a very low cost.  The characterization results of 
the AFE demonstrated cut-off frequencies within 7% and 4.5% and passband gains within 
1.5% and 2.5% of the design specification (for the 20 dB and 40 dB gain settings 
respectively) with very low harmonic distortion.  In addition the AFE makes up only 15.3% 
of the overall noise of the system with the microphone connected, therefore making the 
microphone the limiting factor of system noise which is ideal.  In addition, by 
implementing the joint sound system into a compact and lightweight design, joint acoustics 
during complex movements can now be studied in detail as they relate to quantification of 
knee joint integrity.  Future results from this system could potentially lead to the 
understanding of acoustical emissions as a meaningful biomarker for osteoarthritis 
diagnosis and prognosis, as well as develop a better understanding of the effects of the 
different treatment methods. 
The developed cuffless blood pressure systems achieve semi-continuous 
monitoring of PTT for out-of-clinic BP estimation in both a wearable watch and home 
based scale design.  The real-time classification of PPG signals, coupled with the 
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implemented array of PPG sensors dramatically improves the robustness of the distal 
timing detection against user placement error.  While the array of PPG sensors triples the 
coverage area, including low quality signals significantly degrades the overall 
measurement.  Without a classification algorithm, the PPG array could, in fact, reduce the 
effectiveness of the distal timing reference detection.  Since the classification algorithm 
was able to correctly classify 88.9% of the validation set, it is unlikely that low quality 
signal from a poorly placed sensor will be included in the distal timing measurement.  This 
ability to utilize an array of sensors, increasing the observed surface area, and classify each 
output, ensuring low-quality data is disregarded, both increases the reliability of the 
measured PTT and decreases the amount of time required to obtain a quality distal timing 
reference for beat-to-beat PTT. 
The training set used in the logistic regression included data from multiple 
individuals with heart rates ranging from 50-100 beats per minute, at several locations over 
the dorsum of the foot.  This is done in an attempt to ensure that the classification is not 
heart rate or pulse amplitude dependent and can be used for individuals at rest or after 
exercise.  In addition, this also suggests that changes in blood pressure, as a result of arterial 
stiffening or changes in blood volume, will not cause misclassification of the PPG signal 
due to changes in pulse volume.  Furthermore, since this algorithm is based on simple time 
and frequency domain features, it could be easily implemented in a common programming 
language (e.g. Java) for smartphone based PTT extraction systems using PPG as a distal 
timing reference. 
The most significant limitation of the classification algorithm is the five-second 
recording time required to produce a FFT frequency resolution of 0.2 Hz when sampling 
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at 2 kHz.  This does not allow for immediate classification and could result in a significant 
amount of recording time to obtain a quality distal waveform if the array is misplaced 
several times in succession.  This could be mitigated in the future by increasing the number 
of PPG sensors included in the array resulting in even greater coverage area. 
For the wearable prototype, the use of the LIS344ALH accelerometer proved to be 
robust against placement error so long as the measurement was taken with the 
accelerometer held against the lower half of the sternum.  Placement over the thoracic cage 
and upper sternum were not able to produce consistent results for use as a proximal timing 
reference for PTT.  In addition, the negligible changes in mean and variance in R-AO 
measured across the tested force gradient prove that the system is very robust against 
changes in contact pressure.  However, it was clear that the presence of hand movements 
in an individual can severely degrade the quality of the SCG measurement.  Future design 
of the watch based system must account for such tremors and become more robust against 
their effects.   
The strong individual correlations of changes in PEP found using the SCG based 
watch versus traditional ICG (R2 > 0.81 for subjects 1, 3-5, 7-8) demonstrate that the 
proposed concept is a suitable method for obtaining a proximal timing reference for PTT 
measurement.  Furthermore, an R2 value of 0.78 for the aggregated subject data shows a 
strong correlation of detected PEP between the eight subjects.  However, extraction of the 
AO feature proved to be difficult between subjects due to variance in the individual SCG 
waveform shapes.  This complicates the AO extraction and requires the use of ICG to 
determine the AO feature from each subject’s SCG waveform.  As a result, unless a more 
universal AO extraction method can be developed, any individual intending to use this 
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watch based BP estimation system would need to be individually assessed in-clinic to 
determine the specific AO feature based on an ICG calibration. 
Poor correlation results from subjects 2 and 6 are a result of a poorly defined AO 
feature present in the SCG waveforms for these individuals.  This resulted in the 
implemented AO detection algorithm occasionally selecting incorrect features as the AO 
point.  Further investigation into a more robust and universal AO extraction method on a 
larger subject sample size is needed to determine the most optimal means of PEP extraction 
using the watch based SCG system.  In addition, a lower noise accelerometer may be 
required to ensure the AO peak is more prominent in comparison to the sensor noise. 
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CHAPTER 6. CONCLUSION 
Chronic diseases affect a large percentage of the aging population and will continue 
to place stress on global healthcare systems as this segment of the population continues to 
grow (i.e. people are living longer).  Osteoarthritis and hypertension are two of the most 
common chronic diseases which affect older adults, and can significantly diminish an 
individual’s quality of life.  More personalized and preventative care for these diseases is 
dependent upon the ability to identify early risk factors and continuously monitor the 
effects of treatment.  Currently there are no known biomarkers, apart from imaging 
techniques such as X-ray and MRI, which can aid in the diagnosis or prognosis of 
osteoarthritis, and out-of-clinic hypertension monitoring can only be performed by bulky 
oscillometric devices. 
The AFE designed for the joint sound recording system offers a small, ultra-low 
noise, and wide-band design to improve the measured signal quality for characterization of 
the knee joint acoustics as they correlate to specific injuries which will be performed in 
future studies with this system.  In addition, the system was implemented in a wearable 
design to allow for untethered recording during complex movements.  The improved PPG 
array, and quality classification algorithm implemented in the scale based system are 
pertinent to any future BP estimation system using PPG as a distal timing reference for 
PTT measurement.  The watch SCG based system further improves this design to be 
wearable, allowing for more continuous BP tracking where the home-based scale cannot 
be conveniently used.  The future work on this system will require the correlation of 
changes in measured BP with PTT for subjects with and without hypertension.  In addition, 
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the variability in the SCG waveform between subjects should be explored to extract the 
features which are common between all subjects. 
The systems presented in this document were designed to be used for more 
continuous out-of-clinic monitoring of knee joint acoustics and blood pressure estimation 
by capturing longitudinal biomechanical measurements indicative of the chronic disease 
state of an individual dealing with OA or hypertension.  However, because of the nature of 
the measured biomechanical signals, the systems must be designed to be robust against 
user error to eliminate the continuous need of a medical professional.  This results in 
increased emphasis on the physical system design to ensure robust sensor interfaces, the 
analog circuitry to reduce measurement noise, and signal processing to provide automated 
classification and feedback improve out-of-clinic measurement quality.   The progress 
detailed in this document outlines significant steps toward the realization of non-invasive 
assessment of biomechanical signals to improve the efficiency and effectiveness of health 
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